SecBot SecBot
Insider Cluster (7 insiders) ·Filed Jun 3, 2026

NVCR

NovoCure Ltd
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 7 insiders, $0.3M total
Actionable Insight • Neutral

The uniform sale pattern across all directors is consistent with a pre-arranged 10b5-1 plan or tax-withholding event tied to vesting, not a coordinated bearish signal. No C-suite participation and the minuscule dollar amount relative to market cap make this a non-event for traders. Monitor for any subsequent Form 4 filings that clarify the plan structure, but no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$17.99
T+0 close · Jun 3, 2026 · via day close
Latest settled
−0.94%
T+60 · $17.82
Vs SPY
−2.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 4 $17.99entry
  2. T+1 · 6mo ago −4.61%α −2.04% · $17.16
  3. T+5 · 5mo ago −1.56%α +1.00% · $17.71
  4. T+20 · 4mo ago −4.39%α −3.02% · $17.20
  5. T+60 · 3mo ago −0.94%α −2.83% · $17.82
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Seven NovoCure directors sold identical blocks of 2,945 shares each at $15.77 on June 2, 2026, totaling $325K in open-market sales. The uniform size and timing strongly suggest a coordinated sale, likely tied to a pre-arranged plan or tax-related event rather than opportunistic bearish conviction. Two directors also received non-cash stock grants on June 3, further supporting a routine compensation/planning context. At $2.1B market cap, the $325K represents just 0.015% of market cap, well below the 0.1% materiality threshold.

Key Financial Metrics

Direction
selling
Total Value
$325.1K
Insiders
7

Key Facts

  • Seven directors each sold exactly 2,945 shares at $15.7707 on June 2, 2026, identical size and price point across all sellers
  • Total open-market sale value: $325,112.98 (0.015% of $2.1B market cap)
  • Two directors (Vernon W. Anthony and Martin J. Madden) received non-cash stock grants totaling 28,609 shares on June 3, 2026
  • No C-suite executives (CEO, CFO, COO) participated in the sales, only board members
  • Recent 30-day insider activity shows 6 prior sells totaling $279K, suggesting ongoing routine portfolio management

Financial Impact

Total sales of $325K represent 0.015% of market cap, economically trivial

insider ownership

Risk Factors

  • If the sales were not pre-arranged, the unanimity could indicate a shared negative view, but the trivial size makes this unlikely to be material
  • The stock grants on June 3 could trigger additional selling to cover taxes, but amounts remain small

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
77% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NVCR-1780691177500

Track record

20 reports on NVCR

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +19.75% at T+20 after the Feb 27, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $11.83 to $11.30 Now $11.30 −4.48% ▼ −4.48% −2.57% vs SPY
  2. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  3. Nov 9, 20267d ago 144 Neutral 2/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  4. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $12.53 to $11.81 Now $11.30 +9.82% ▲ +5.75% +5.38% vs SPY
  5. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $13.11 to $13.15 Now $11.30 −13.81% ▲ +0.31% +2.08% vs SPY
  6. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $15.92 to $14.94 Now $11.30 −29.02% ▼ −6.16% −6.90% vs SPY
  7. Sep 9, 20269w ago 8-K Neutral 2/10 Entry $15.63 to $15.35 Now $11.30 −27.70% ▼ −1.79% −1.19% vs SPY
  8. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $17.38 to $17.83 Now $11.30 −34.98% ▲ +2.59% +2.15% vs SPY
  9. Jul 23, 202616w ago 8-K Bullish 7/10 Entry $19.99 to $17.65 Now $11.30 −43.47% ▼ −11.71% −11.81% vs SPY
  10. Jun 30, 202619w ago 8-K Bullish 7/10 Entry $15.15 to $15.78 Now $11.30 −25.41% ▲ +4.16% +4.29% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens Wed (10h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026